Infection control technology company HandInScan closes series A funding round

Published: 15-Jan-2016

Investment to be used to initiate global commercialisation and accelerate R&D


HandInScan Ltd, an innovative health technology company focusing on hand hygiene control, has announced the closing of an investment of US$1.45m by Perion Investment Fund.

The proceeds will be used to expedite the commercialisation of HandInScan’s flagship product, the Hand-in-Scan Medical Trainer, and to further develop its disruptive technology and service portfolio.

The benefits of HandInScan's innovative products and services are the increased compliance with hand sanitisation, and the significant reduction of healthcare-associated infections.

Dr Tamas Haidegger, CEO of HandInScan, said: ‘We are proud to join forces with Perion Investment, whose team has great experience in supporting companies towards commercialisation and shareholder value creation. We are also very grateful to our early stage partner, DBH Investment, who supported the company from the concept and start-up phase through product development. As a result, we were able to close a successful series A investment round.’

Gabor Vitan, CEO of Perion Investment, said: ‘Having developed a disruptive technology ready for commercialisation, HandInScan was a great match for our investment philosophy and strategy. Our team was very impressed with the product, the management and the advisory team as well. We believe that the next few years will be a turning point for the company as the sector experiences rapid transition and growth.’

You may also like